TCM Ltd Q2 FY26 – From Solar Dreams to Cattle Feeds, This 82-Year-Old Chemical Relic Just Can’t Sit Still!
1. At a Glance
Welcome to the world of TCM Ltd, a company so old it was born before India’s independence, yet so restless it changes business models faster than your Netflix recommendations. Once a proud chemical manufacturer, now moonlighting as a solar power installer, healthcare trader, feed manufacturer, and even EdTech dealer, TCM has mastered the art of corporate multitasking — or confusion, depending on your optimism level.
As of December 2025, the stock sits at ₹69.8, up a spicy 53.8% in just three months. With a market cap of ₹52.2 crore and a P/E ratio of 348, it’s priced like a tech unicorn but earns like a local photocopy shop. Sales for the quarter ended September 2025 stood at ₹5.92 crore, while the bottom line stubbornly displayed a loss of ₹0.83 crore — proving that even after 82 years, TCM still believes in tradition: keeping shareholders perpetually hopeful.
Operating margin? -14%, just enough to keep the auditors awake at night. And yet, the ROE of 6.04% suggests that someone, somewhere, is still making a little money out of this circus.
2. Introduction
If TCM Ltd were a person, it would be that senior citizen uncle who refuses to retire, still trying new hobbies every year — first chemistry, then solar panels, then cattle feed. Born in 1943, the company’s initials originally stood for “Travancore Chemical & Manufacturing,” but today, it might as well mean “Trying Constantly to Monetize”.
After years of struggling in the chemicals business (and let’s be honest, who can blame them — their Tuticorin and Mettur units have been sleeping since 2012), TCM found salvation in buzzwords: solar energy, healthcare devices, and AI-based educational kits. If you’ve ever wondered what happens when an old chemical company reads too many startup news articles, look no further.
The company’s balance sheet looks like a family WhatsApp group — full of old things, new experiments, and a few embarrassing photos (read: losses). But here’s the fun part: despite negative operating margins and modest revenues, the share price has doubled in six months. Why? Because TCM is now a story stock — a blend of nostalgia, solar ambitions, and the faint smell of disinfectant.
Will this ancient alchemist finally strike gold by mixing healthcare, solar panels, and poultry feed? Let’s find out.
3. Business Model – WTF Do They Even Do?
TCM Ltd today is a buffet of businesses — each serving a completely different course:
TCM Healthcare: The company’s new-age baby. It sells medical testing kits, gloves, and home devices. They even opened a new 1,621 sq. ft office in Maradu, Ernakulam, proving that healthcare is serious business — or at least serious rent.
TCM Automotive: Makes GPS-enabled Automatic Headlight Beam Assist Systems under the brand ENSO. Yes, you read that right. From chlorine chemicals to car headlights — talk about diversification with no GPS.
TCM Solar: Installs solar panels and inverters, with government tie-ups like the Kerala Solar City Project, bagging a ₹1.1 crore order. More recently, they received a ₹7.92 crore order from CIAL for a 7.5 MWp reinstallation project. Clearly, TCM’s sun is rising again.
TCM Green Earth & Aquaculture: Venturing into fish and shrimp breeding because, why not? If you can’t produce chlorine, at least produce tilapia.
International Trading: Trades commodities like fuel oil, pulses, meat, and minerals — basically, if it moves or burns, TCM might sell it.
Online Education: The wildcard segment — making AI/ML kits, robotics, and student response devices. Because when you’re this diversified, logic is optional.
If confusion had a business plan, it would look like TCM’s portfolio.
4. Financials Overview
Let’s open the financial lab.
Metric (₹ Cr)
Q2 FY26 (Sep 2025)
Q2 FY25 (Sep 2024)
Q1 FY26 (Jun 2025)
YoY %
QoQ %
Revenue
5.92
6.90
3.21
-14.2%
+84.4%
EBITDA
-0.83
-0.59
-1.96
—
+57.6%
PAT
-0.83
-0.63
-2.35
—
+64.7%
EPS (₹)
-1.04
-0.76
-3.00
—
+65.3%
Commentary: Revenue fell YoY but doubled sequentially. PAT is still negative but losses narrowed sharply. That’s
